0001567619-20-013884.txt : 20200729 0001567619-20-013884.hdr.sgml : 20200729 20200729161201 ACCESSION NUMBER: 0001567619-20-013884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200727 FILED AS OF DATE: 20200729 DATE AS OF CHANGE: 20200729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Medpace Investors, LLC CENTRAL INDEX KEY: 0001524599 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37856 FILM NUMBER: 201057418 BUSINESS ADDRESS: STREET 1: 4620 WESLEY AVENUE CITY: CINCINNATI STATE: OH ZIP: 45212 BUSINESS PHONE: 513-579-9911 MAIL ADDRESS: STREET 1: 4620 WESLEY AVENUE CITY: CINCINNATI STATE: OH ZIP: 45212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medpace Holdings, Inc. CENTRAL INDEX KEY: 0001668397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 320434904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 BUSINESS PHONE: (513) 579-9911 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 4 1 doc1.xml FORM 4 X0306 4 2020-07-27 0 0001668397 Medpace Holdings, Inc. MEDP 0001524599 Medpace Investors, LLC C/O MEDPACE HOLDINGS, INC. 5375 MEDPACE WAY CINCINNATI OH 45227 0 0 1 0 Common Stock 2020-07-27 4 S 0 29019 110.43 D 7542057 D Common Stock 2020-07-28 4 S 0 214499 127.23 D 7327558 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $106.69 to $112.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $116.765 to $143.965. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. /s/ Stephen P. Ewald, Authorized Signatory for Medpace Investors, LLC 2020-07-29